BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li Y, Zhao ZG, Luo Y, Cui H, Wang HY, Jia YF, Gao YT. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma. World J Gastroenterol 2020; 26(32): 4786-4801 [PMID: 32921957 DOI: 10.3748/wjg.v26.i32.4786]
URL: https://www.wjgnet.com/1007-9327/full/v26/i32/4786.htm
Number Citing Articles
1
Aadil Javed, Gianluca Malagraba, Mahdieh Yarmohammadi, Catalina M. Perelló-Reus, Carles Barceló, Teresa Rubio-Tomás. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal SystemFuture Pharmacology 2022; 2(3): 214 doi: 10.3390/futurepharmacol2030015
2
Yuyao Li, Yue Li, Xuemei Zhang, Xiangjuan Duan, Hai Feng, Zhuo Yu, Yueqiu Gao. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.986827
3
Keying Liang, Qian Wang, Li Qiu, Xiaocheng Gong, Zixi Chen, Haibo Zhang, Ke Ding, Yunfei Liu, Jinfen Wei, Shudai Lin, Shuying Fu, Hongli Du. Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-CancerInternational Journal of Molecular Sciences 2023; 24(21): 15658 doi: 10.3390/ijms242115658
4
阳春 胡. Quercetin Targeting BIRC5 Inhibits the Proliferation of Glioblastoma and Affects the Prognosis Based on Bioinformatics and Network Pharmacology AnalysisAdvances in Clinical Medicine 2023; 13(01): 928 doi: 10.12677/ACM.2023.131134
5
Chao Yang, Dan Li, Shaohong Zang, Lei Zhang, Zhangfeng Zhong, Yingtang Zhou. Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1AFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.955218
6
Honghao Yang, Yilan Zhao, Xiaojiao Zheng, Xiulian Ju, Fengshou Wu, Xiaogang Luo, Qi Sun, Genyan Liu. Exploring Novel PLK1 Inhibitors based on Computational Studies of 2,4-Diarylaminopyrimidine DerivativesLetters in Drug Design & Discovery 2024; 21(5): 979 doi: 10.2174/1570180820666230801114905
7
Shengqin Su, Gagan Chhabra, Chandra K. Singh, Mary A. Ndiaye, Nihal Ahmad. PLK1 inhibition-based combination therapies for cancer managementTranslational Oncology 2022; 16: 101332 doi: 10.1016/j.tranon.2021.101332
8
Yan Li, William Lee, Zhen-Gang Zhao, Yi Liu, Hao Cui, Hao-Yu Wang. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinomaWorld Journal of Clinical Oncology 2024; 15(1): 130-144 doi: 10.5306/wjco.v15.i1.130
9
Xuan Wu, Shen-Ying Yang, Yi-Hua Zhang, Jin-Zhou Fang, Shuai Wang, Zhi-Wei Xu, Xiao-Ju Zhang. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinomaWorld Journal of Clinical Oncology 2024; 15(1): 45-61 doi: 10.5306/wjco.v15.i1.45